228 related articles for article (PubMed ID: 35853538)
1. Predictive biomarkers for personalized medicine in breast cancer.
Rodrigues-Ferreira S; Nahmias C
Cancer Lett; 2022 Oct; 545():215828. PubMed ID: 35853538
[TBL] [Abstract][Full Text] [Related]
2. ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients.
Fekete JT; Győrffy B
Int J Cancer; 2019 Dec; 145(11):3140-3151. PubMed ID: 31020993
[TBL] [Abstract][Full Text] [Related]
3. Resistance to endocrine therapy in HR + and/or HER2 + breast cancer: the most promising predictive biomarkers.
Miranda F; Prazeres H; Mendes F; Martins D; Schmitt F
Mol Biol Rep; 2022 Jan; 49(1):717-733. PubMed ID: 34739691
[TBL] [Abstract][Full Text] [Related]
4. Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer.
Haykal MM; Rodrigues-Ferreira S; Nahmias C
Cells; 2021 May; 10(5):. PubMed ID: 34062782
[TBL] [Abstract][Full Text] [Related]
5. Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers?
Music M; Prassas I; Diamandis EP
Crit Rev Clin Lab Sci; 2018 Nov; 55(7):466-479. PubMed ID: 30277835
[TBL] [Abstract][Full Text] [Related]
6. Updates on breast biomarkers.
Najjar S; Allison KH
Virchows Arch; 2022 Jan; 480(1):163-176. PubMed ID: 35029776
[TBL] [Abstract][Full Text] [Related]
7. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.
Kern R; Correa SC; Scandolara TB; Carla da Silva J; Pires BR; Panis C
Per Med; 2020 Sep; 17(5):399-420. PubMed ID: 32804054
[TBL] [Abstract][Full Text] [Related]
8. Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer.
Dey A; Mitra A; Pathak S; Prasad S; Zhang AS; Zhang H; Sun XF; Banerjee A
Technol Cancer Res Treat; 2023; 22():15330338231178403. PubMed ID: 37248615
[TBL] [Abstract][Full Text] [Related]
9. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
[TBL] [Abstract][Full Text] [Related]
10. Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer.
Marchio C; Balmativola D; Castiglione R; Annaratone L; Sapino A
Curr Drug Targets; 2017; 18(1):4-12. PubMed ID: 25654739
[TBL] [Abstract][Full Text] [Related]
11. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
12. A framework to predict the applicability of Oncotype DX, MammaPrint, and E2F4 gene signatures for improving breast cancer prognostic prediction.
Yao K; Tong CY; Cheng C
Sci Rep; 2022 Feb; 12(1):2211. PubMed ID: 35140308
[TBL] [Abstract][Full Text] [Related]
13. The Breast Cancer Proteome and Precision Oncology.
Lei JT; Jaehnig EJ; Smith H; Holt MV; Li X; Anurag M; Ellis MJ; Mills GB; Zhang B; Labrie M
Cold Spring Harb Perspect Med; 2023 Oct; 13(10):. PubMed ID: 37137501
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Breast Cancer: An Old Story with a New End.
Neves Rebello Alves L; Dummer Meira D; Poppe Merigueti L; Correia Casotti M; do Prado Ventorim D; Ferreira Figueiredo Almeida J; Pereira de Sousa V; Cindra Sant'Ana M; Gonçalves Coutinho da Cruz R; Santos Louro L; Mendonça Santana G; Erik Santos Louro T; Evangelista Salazar R; Ribeiro Campos da Silva D; Stefani Siqueira Zetum A; Silva Dos Reis Trabach R; Imbroisi Valle Errera F; de Paula F; de Vargas Wolfgramm Dos Santos E; Fagundes de Carvalho E; Drumond Louro I
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510269
[TBL] [Abstract][Full Text] [Related]
15. Update on prognostic and predictive biomarkers of breast cancer.
Hou Y; Peng Y; Li Z
Semin Diagn Pathol; 2022 Sep; 39(5):322-332. PubMed ID: 35752515
[TBL] [Abstract][Full Text] [Related]
16. Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer.
Costa B; Vale N
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328602
[TBL] [Abstract][Full Text] [Related]
17. Theranostic Interpolation of Genomic Instability in Breast Cancer.
Rasool R; Ullah I; Mubeen B; Alshehri S; Imam SS; Ghoneim MM; Alzarea SI; Al-Abbasi FA; Murtaza BN; Kazmi I; Nadeem MS
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163783
[TBL] [Abstract][Full Text] [Related]
18. Current Biomarkers for Precision Medicine in Breast Cancer.
Ahn SK; Jung SY
Adv Exp Med Biol; 2021; 1187():363-379. PubMed ID: 33983588
[TBL] [Abstract][Full Text] [Related]
19. Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an
Parachoniak CA; Rankin A; Gaffney B; Hartmaier R; Spritz D; Erlich RL; Miller VA; Morosini D; Stephens P; Ross JS; Keech J; Chmielecki J
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28550065
[TBL] [Abstract][Full Text] [Related]
20. Circulating biomarkers predictive of tumor response to cancer immunotherapy.
Lee EY; Kulkarni RP
Expert Rev Mol Diagn; 2019 Oct; 19(10):895-904. PubMed ID: 31469965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
